Arendrup, MC;
Armstrong-James, D;
Borman, AM;
Denning, DW;
Fisher, MC;
Gorton, R;
Maertens, J;
Martin-Loeches, I;
Mehra, V;
Mercier, T;
et al.
Arendrup, MC; Armstrong-James, D; Borman, AM; Denning, DW; Fisher, MC; Gorton, R; Maertens, J; Martin-Loeches, I; Mehra, V; Mercier, T; Price, J; Rautemaa-Richardson, R; Wake, R; Andrews, N; White, PL
(2024)
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective.
Open Forum Infect Dis, 11 (7).
ofae372.
ISSN 2328-8957
https://doi.org/10.1093/ofid/ofae372
SGUL Authors: Wake, Rachel Marie
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (682kB) | Preview |
Abstract
Fungal diseases represent a considerable global health concern, affecting >1 billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list (FPPL) in late 2022. The FPPL highlights the challenges in estimating the global burden of fungal diseases and antifungal resistance (AFR), as well as limited surveillance capabilities and lack of routine AFR testing. Furthermore, training programs should incorporate sufficient information on fungal diseases, necessitating global advocacy to educate health care professionals and scientists. Established international guidelines and the FPPL are vital in strengthening local guidance on tackling fungal diseases. Future iterations of the FPPL have the potential to refine the list further, addressing its limitations and advancing our collective ability to combat fungal diseases effectively. Napp Pharmaceuticals Limited (Mundipharma UK) organized a workshop with key experts from Northern Europe to discuss the impact of the FPPL on regional clinical practice.
Item Type: | Article | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | ||||||
Keywords: | WHO fungal priority pathogen list, fungal diagnostics, fungal surveillance, mycology, fungal diagnostics, fungal surveillance, mycology, WHO fungal priority pathogen list | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) Academic Structure > REF 2021 user group |
||||||
Journal or Publication Title: | Open Forum Infect Dis | ||||||
ISSN: | 2328-8957 | ||||||
Language: | eng | ||||||
Dates: |
|
||||||
Publisher License: | Creative Commons: Attribution 4.0 | ||||||
PubMed ID: | 39045012 | ||||||
Web of Science ID: | WOS:001274423500002 | ||||||
Go to PubMed abstract | |||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/116759 | ||||||
Publisher's version: | https://doi.org/10.1093/ofid/ofae372 |
Statistics
Actions (login required)
![]() |
Edit Item |